Archives of Disease in Childhood 2007;92:704-707
ORIGINAL ARTICLE
Does treatment of newly diagnosed idiopathic thrombocytopenic purpura reduce morbidity?
1 Sachs’ Children’s Hospital, Stockholm, Sweden
2 Paediatric Department, Jorvi Hospital, University of Helsinki, Finland
3 Paediatric Department, Rikshospitalet, Oslo, Norway
4 Childhood Cancer Research Unit, Department of Woman and Child Health, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
5 Paediatric Department, Aalborg Hospital, Denmark
Correspondence to:
Dr S Rosthøj
Paediatric Department, Aalborg Hospital, Reberbansgade, 9100 Aalborg, Denmark; steen.rosthoej{at}rn.dk
Aim: To explore whether early treatment of children with idiopathic thrombocytopenic purpura (ITP) with immunoglobulin and/or corticosteroids reduces subsequent morbidity.
Methods: Centres participating in a Nordic ITP study were divided according to whether they had treated more than 2/3, from 1/3 to 2/3, or less than 1/3 children within 14 days of diagnosis. The course of disease from 15 days to 6 months after diagnosis was compared for children managed at the three centre categories. The comparison was restricted to children in whom at least one platelet count <20x109/l was measured, numbering 156, 143 and 84 in the three different categories, respectively.
Results: The three groups of children were clinically similar but were managed with initial treatment rates of 89%, 57% and 14%, respectively. By day 15, the platelet count had stabilised to >20x109/l in 67%, 67% and 52% (p<0.05) and to >150x109/l in 38%, 29% and 29% (p<0.20). At 1 month after diagnosis there was no difference in recovery rates. Chronic ITP developed in 27%, 22% and 25% in the three groups. During follow-up, one or more disease-related events occurred in 23%, 22% and 19%, with no difference in the average numbers of episodes with mucosal bleeding. Treatment courses were administered to 19%, 13% and 11%, respectively.
Conclusion: Active treatment policies accelerated platelet recovery in children with short-lasting ITP but did not avert the development of chronic ITP and did not cause a reduction in morbidity during follow-up.
Abbreviations: CS, corticosteroids; ITP, idiopathic thrombocytopenic purpura; IVIG, intravenous immunoglobulin
Keywords: idiopathic thrombocytopenic purpura; immunoglobulin therapy; corticosteroid therapy
Relevant Article
Read all eLetters
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
Arch. Dis. Child. 2007 92: e8.
eLetters:
- Full Text
- Full Text (PDF)
-
All Versions of this Article:
adc.2006.098442v1
92/8/704 most recent - Submit a response
- Read responses to this article
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in ADC Online
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
